Viewing Study NCT00127569

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:50 PM
Ignite Modification Date: 2026-01-16 @ 9:15 AM
Study NCT ID: NCT00127569
Status: TERMINATED
Last Update Posted: 2007-01-12
First Post: 2005-08-04
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Rituximab in the Treatment of HIV Associated Multicentric Castleman Disease Dependent on Chemotherapy
Sponsor: French National Agency for Research on AIDS and Viral Hepatitis
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HIV Infections View
None Giant Lymph Node Hyperplasia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HIV infections View
None Giant Lymph Node Hyperplasia View
None Herpesvirus 8, Human View
None Rituximab (Mabthera) View
None Antibodies, Monoclonal View